Joan E. Booth

Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

Deepak L. Bhatt, Keith A.A. Fox, Werner Hacke et al. · New England Journal of Medicine · 2006 · 2.8K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

A. Michael Lincoff, Robert M. Califf, David J. Moliterno et al. · New England Journal of Medicine · 1999 · 379 citations

Medicine, Cardiology, Pharmacotherapy +17

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

Eric J. Topol, Daniel B. Mark, A. Michael Lincoff et al. · The Lancet · 1999 · 329 citations

Medicine, Cardiology, Pharmacoeconomics +16

Optimizing the Percutaneous Interventional Outcomes for Patients With Diabetes Mellitus

Steven P. Marso, A. Michael Lincoff, Stephen G. Ellis et al. · Circulation · 1999 · 288 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Sustained Suppression of Ischemic Complications of Coronary Intervention by Platelet GP IIb/IIIa Blockade With Abciximab

A. Michael Lincoff, James E. Tcheng, Robert M. Califf et al. · Circulation · 1999 · 157 citations

Medicine, Cardiology, Pharmacotherapy +15